Scott H Robbins is a notable inventor based in Lake Forest Park, WA (US). He has made significant contributions to the field of vaccine development, holding a total of four patents. His work primarily focuses on innovative solutions for combating viral infections.

Latest Patents

Among his latest patents, Robbins has developed vaccines for HSV-2. These vaccines consist of compositions of recombinant HSV-2 proteins combined with an agonist of the innate immune system, such as an adjuvant. The proteins include an envelope glycoprotein and a structural protein, which may be a capsid or tegument protein. This vaccine is designed for use in both HSV-2 seropositive and seronegative subjects.

Career Highlights

Robbins is currently associated with Immune Design Corp., where he continues to advance his research and development efforts. His innovative approach to vaccine formulation has positioned him as a key player in the field of immunology.

Collaborations

Throughout his career, Robbins has collaborated with esteemed colleagues, including Thomas W Dubensky, Jr. and Nancy Ann Hosken. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking vaccine technologies.

Conclusion

Scott H Robbins exemplifies the spirit of innovation in the field of vaccine development. His contributions are paving the way for new treatments and preventive measures against viral infections.

This text is generated by artificial intelligence and may not be accurate.